Dr. Vincent C. Giampapa, MD is a world-renowned medical doctor, inventor, and surgeon specializing in anti-aging medicine. He is one of the first Board Certified anti-aging physicians in the world. He is a co-founder of the American Academy of Anti-Aging Medicine and the first president of the American Board of Anti-Aging Medicine.

Dr. Giampapa is the founder of the Regenerative Medicine Institute (RMI), located in Costa Rica, and is a visiting scholar at the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School.

Dr. Giampapa was nominated for a Nobel Prize in both 2014 and 2015 for his groundbreaking research into cellular restoration technology. He also received a Gusi Peace Prize for his work in stem cell reprogramming. He received an Edison Award for developing the first epigenetic nutritional supplement and an A4M Science & Technology Award for developing the BioMarker Matrix Profile—the first computer program to measure aging. He served as a NASA consultant for the space shuttle robotic arm and has been awarded 24 patents from the United States Government for unique cell culture delivery techniques, stem cell reprogramming, new drug delivery systems, and surgical instrument designs.

Dr. Giampapa is the author of five books on health and longevity and the first medical textbook on Anti-Aging Medicine and Age Management. Based on 34 years of surgical experience and 25 years of research, Dr. Giampapa is passionate about extending healthy life spans with enhanced functions. He views the global aging dilemma as one of the critical challenges for humanity in the next decade. His research focuses on stem cells and our body’s innate ability to regenerate and maintain a longer and healthier life span.